Catalyst Wire Dossier Catalyst Wire Dossier

gp145 C.6980 HIV vaccine

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for gp145 C.6980 HIV vaccine, covering 2021-07-27 to 2021-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States [Phase 1]

See pricing